Early treatment in HCV : is it a cost-utility option from the Italian perspective?

Marcellusi, Andrea, Viti, Raffaella, Damele, Francesco, Camma, Calogero, Taliani, Gloria and Mennini, Francesco Saverio (2016) Early treatment in HCV : is it a cost-utility option from the Italian perspective? Clinical Drug Investigation, 36(8), pp. 661-672. ISSN (print) 1173-2563

Full text not available from this archive.

Abstract

Our model represents a tool for policy makers and health-care professionals, and provided information on the cost-utility of the early-treatment approach in HCV-infected patients in Italy. Starting innovative treatment regimens earlier keeps HCV-infected patients in better health and reduces the incidence of HCV-related events; generating a gain both in terms of health of the patients and correct resource allocation.

Item Type: Article
Research Area: Business and management studies
Health services research
Faculty, School or Research Centre: Faculty of Business and Law
Faculty of Business and Law > Kingston Business School (Accounting, Finance and Informatics) (from August 2013)
Related URLs:
Depositing User: Automatic Import Agent
Date Deposited: 08 Jul 2016 12:54
Last Modified: 02 Jun 2017 08:25
URI: http://eprints.kingston.ac.uk/id/eprint/35229

Actions (Repository Editors)

Item Control Page Item Control Page